Concepedia

Liping Chang

LC

Statistics

Publications

10

Citations

311

H-Index

10

Active since

2016

Affiliations

Hebei Medical University(Current)

Shijiazhuang Yiling Pharmaceutical (China)

Hebei Yiling Hospital

Hebei University of Chinese Medicine

Nanjing University of Chinese Medicine

Liping Chang is an author at Hebei Medical University specializing in medicine, pharmacology, and cardiovascular pharmacotherapy.

ORCID

Publications per year

2016–2024

10

Publications

10

LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway

Hongrong Li, Qifei Zhao, Liping Chang et al. · Lipids in Health and Disease · 2019 · 80 citations · Full text

, , +13

Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction

Yafen Wang, Xiangnan Kuang, Yujie Yin et al. · Biomedicine & Pharmacotherapy · 2021 · 52 citations · Full text

, , +17

Chinese medicine Bazi Bushen capsule improves lipid metabolism in ovariectomized female ApoE−/− mice

Dan Huang, Huawei Hu, Liping Chang et al. · Annals of Palliative Medicine · 2020 · 33 citations · Full text

, , +14

Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition

Yujie Yin, Qian Zhang, Qifei Zhao et al. · BioMed Research International · 2019 · 31 citations · Full text

, , +17

Gypenoside A protects ischemia/reperfusion injuries by suppressing miR‐143‐3p level via the activation of AMPK/Foxo1 pathway

Liping Chang, Rui Shi, Xiujiang Wang et al. · BioFactors · 2019 · 27 citations

, , +16

1–5 of 10